Construction and characterization of new piggyBac vectors for constitutive or inducible expression of heterologous gene pairs and the identification of a previously unrecognized activator sequence in piggyBac by Shi, Xianzong et al.
BioMed  Central
Page 1 of 17
(page number not for citation purposes)
BMC Biotechnology
Open Access Research article
Construction and characterization of new piggyBac vectors for 
constitutive or inducible expression of heterologous gene pairs and 
the identification of a previously unrecognized activator sequence 
in piggyBac
Xianzong Shi1,2, Robert L Harrison1,2,4, Jason R Hollister1,5, 
Ahmed Mohammed3, Malcolm J Fraser Jr3 and Donald L Jarvis*1
Address: 1Department of Molecular Biology University of Wyoming 1000 E. University Avenue Laramie, WY, USA 82071, 2Chesapeake-PERL, Inc. 
8510A Corridor Rd Savage, MD, USA 20763, 3Department of Biological Sciences University of Notre Dame Notre Dame, IN, USA 46556-0369, 
4USDA, ARS, PSI Insect Biocontrol Lab Building 011A, Room 214, BARC-W 10300 Baltimore Ave.Beltsville, MD, USA 20705 and 5USDA, ARS, 
NAA, PIADC Plum Island Animal Disease Center P.O. BOX 848, GREENPORT, LI Orient Point, NY, USA 11944
Email: Xianzong Shi - xianzong@uwyo.edu; Robert L Harrison - harrisor@ba.ars.usda.gov; 
Jason R Hollister - jason.hollister@piadc.ars.usda.gov; Ahmed Mohammed - amohamme@nd.edu; Malcolm J Fraser - fraser.1@nd.edu; 
Donald L Jarvis* - dljarvis@uwyo.edu
* Corresponding author    
Abstract
Background:  We constructed and characterized several new piggyBac  vectors to provide
transposition of constitutively- or inducibly-expressible heterologous gene pairs. The dual
constitutive control element consists of back-to-back copies of a baculovirus immediate early (ie1)
promoter separated by a baculovirus enhancer (hr5). The dual inducible control element consists
of back-to-back copies of a minimal cytomegalovirus (CMVmin) promoter separated by a synthetic
operator (TetO7), which drives transcription in the presence of a mutant transcriptional repressor
plus tetracycline.
Results:  Characterization of these vectors revealed an unexpected position effect, in which
heterologous genes adjacent to the 3'- terminal region ("rightward" genes) were consistently
expressed at higher levels than those adjacent to the 5'-terminal region ("leftward" genes) of the
piggyBac element. This position effect was observed with all six heterologous genes examined and
with both transcriptional control elements. Further analysis demonstrated that this position effect
resulted from stimulation of rightward gene expression by the internal domain sequence of the 3'-
terminal region of piggyBac. Inserting a copy of this sequence into the 5'- terminal repeat region of
our new piggyBac vectors in either orientation stimulated leftward gene expression. Representative
piggyBac vectors designed for constitutive or inducible expression of heterologous gene pairs were
shown to be functional as insect transformation vectors.
Conclusion: This study is significant because (a) it demonstrates the utility of a strategy for the
construction of piggyBac vectors that can provide constitutive or inducible heterologous gene pair
expression and (b) it reveals the presence of a previously unrecognized transcriptional activator in
piggyBac, which is an important and increasingly utilized transposable element.
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Background
piggyBac is a class II transposable element that was origi-
nally discovered as the IFP2 element from the lepidop-
teran insect cell line, TN-368, due to its tendency to
insertionally inactivate certain baculovirus genes to pro-
duce mutants with a distinctive plaque phenotype known
as Few Polyhedra [1,2]. Functionally, piggyBac encodes a
transposase with a precise cut and paste mechanism and a
unique preference for TTAA sites [3-6]. Thus, it is consid-
ered to be the type element of the TTAA-specific transpo-
son family [7]. Structurally, piggyBac  is a 2.4 kb DNA
molecule with a single 1.8 kb open reading frame that ter-
minates on both ends with 13 bp perfect inverted termi-
nal repeat domains (TRD's). piggyBac  also has two
additional 19 bp subterminal inverted repeats located
asymmetrically 31 bp from the 5'-TRD and 3 bp from the
3'-TRD [4]. Sequences similar to the piggyBac open read-
ing frame have been identified in all animal species for
which extensive genomic sequences are available, includ-
ing the human. However, most appear to be either incom-
plete or interrupted and, therefore, probably do not
encode functional transposons [8].
The mobility and transposition functions of piggyBac have
been established and exploited to develop an important
binary system for insect germline transformation [3]. This
system consists of a DNA vector, which can be mobilized
due to the presence of the piggyBac  5'- and 3'-TRD
sequences, and a helper plasmid, which encodes the trans-
posase. The vector also includes a promoter, which con-
trols transcription of an inserted, heterologous gene of
interest, and a whole-body or eye color marker, which can
be used to identify transgenic offspring.
The Mediterranean fruit fly was the first target organism to
be successfully transformed using the piggyBac system [9]
and it has subsequently been used to transform a wide
variety of insects (reviewed in reference [10]). Recently,
the  piggyBac  system has been used to transform many
other types of organisms ranging from the protist, Plasmo-
dium falciparum [11] to the mouse, Mus musculus [12].
Thus, piggyBac is widely and increasingly recognized as an
important tool for genetic transformation in many differ-
ent biological systems.
Current piggyBac vectors are designed to introduce a single
heterologous gene of interest into the genome of a target
organism, in addition to the marker gene. However, some
transgenic approaches require the introduction of multi-
ple heterologous genes of interest into a single target
organism. To meet this requirement, we constructed a
new set of piggyBac vectors designed to simultaneously
transfer pairs of heterologous genes placed under the con-
trol of dual constitutive or regulated transcriptional ele-
ments, which included duplicate promoters in a back-to-
back configuration. One advantage of this approach is
that it allowed us to couple both promoters to a single
enhancer or regulatory domain, which minimized the
overall size of the transcriptional control region.
During the process of characterizing the induction of het-
erologous gene expression in lepidopteran insect cells by
these new piggyBac vectors, we discovered an unexpected
position effect, in which the rightward-oriented heterolo-
gous genes were consistently expressed at higher levels
than the leftward-oriented ones. Further analysis revealed
that this was the result of stimulation by a previously
unrecognized activator element in the 3'-TRD of piggyBac.
We subsequently duplicated this activating sequence and
used it to balance expression of the rightward and leftward
heterologous genes in our new vectors. Thus, this study
yielded not only a substantial set of new piggyBac vectors,
but also provided new basic information on this impor-
tant transposable element, both of which will be of gen-
eral interest to the biomedical research community.
Results and Discussion
New piggyBac vectors for transfer and constitutive or 
inducible expression of heterologous gene pairs
Previous studies have established that the addition of six
mammalian genes can effectively humanize the protein
N-glycosylation pathway of Sf9, a lepidopteran insect cell
line (reviewed in references [13,14]). One of our current
projects is designed to extend those studies by using these
same genes to humanize the protein N-glycosylation
pathway in an intact, multicellular lepidopteran insect.
The piggyBac vector system was an obvious tool to use for
this purpose. However, we were concerned about the effi-
cacy of an attempt to use six separate vectors and, realizing
that there were no piggyBac vectors that could be used to
simultaneously transform an insect with multiple genes,
we decided to construct a new set of vectors that could be
used to transform a target organism with pairs of heterol-
ogous genes. We had previously designed and constructed
plasmid vectors containing a transcriptional control ele-
ment consisting of two back-to-back baculovirus immedi-
ate early gene (ie1) promoters separated by a baculovirus
(hr5) enhancer [15,16]. In addition, we had inserted pairs
of heterologous genes into these vectors and used the
resulting constructs to transform lepidopteran insect cell
lines independently of piggyBac and to isolate derivatives
that constitutively expressed both heterologous genes
[15,16]. Thus, we chose to construct a new set of piggyBac
vectors in which pairs of heterologous genes could be
placed under the control of the dual ie1-hr5-ie1 control
element. We also considered that producing viable or fer-
tile transgenic insect lines that constitutively express
mammalian N-glycan processing genes might not be pos-
sible. Therefore, we constructed a second new set of piggy-
Bac vectors in which pairs of heterologous genes could beBMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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placed under the control of a mosaic, tetracycline-induci-
ble control element, which consisted of two back-to-back
copies of the minimal human cytomegalovirus immedi-
ate early gene promoter (PCMVmin) separated by an opera-
tor (TetO7). This transcriptional control element had been
shown to provide tetracycline-inducible gene expression
in an insect system [17]. In addition to these transcrip-
tional elements and heterologous gene pairs, each of these
new piggyBac vectors also contained one of three different
fluorescent protein-encoding genes under the control of
an insect eye-specific promoter (3xP3; Horn, 2000
#1379], which could be used to identify transgenic off-
spring. The details of the cloning schemes used to con-
struct the new piggyBac vectors described in this study are
given in Materials and Methods and the cloning schemes
and key genetic features of the new vectors are shown dia-
grammatically in Figs. 1, 2, 3, 4. The structure of each vec-
tor was analyzed in detail by restriction mapping, PCR,
and/or DNA sequencing, as described in Materials and
Methods. Subsequently, transient expression assays were
performed to examine their functionality.
An unexpected position effect on heterologous gene 
expression by the new piggyBac vectors
The molecular cloning schemes used in this study initially
yielded four sets of piggyBac vectors in which six different
heterologous genes were placed under the control of the
constitutive or inducible regulatory elements described
above (Fig. 4). Six of these vectors had the three "Glyco-A"
genes (GnTII, ST6GalI, and SAS) with a rightward orienta-
tion (Fig. 4, Sets 1 and 3), while the other six had these
same genes with a leftward oriention (Fig. 4, Sets 2 and 4)
with respect to the 5'- and 3'-TRD elements of piggyBac, as
defined by Li and coworkers [18].
The first set of transient expression assays focused on the
ability of the piggyBac vectors containing the dual consti-
tutive transcriptional element (ie1-hr5-ie1) to induce het-
erologous gene expression. Unexpectedly, the results
showed that the vectors containing the rightward heterol-
ogous genes induced higher levels than those containing
the leftward genes (Fig. 5). For example, cells transfected
with the piggyBac vector containing the GnTII gene in the
rightward orientation (vector A in Column A, Fig. 5) had
about 4.5X more GnTII activity than cells transfected with
the piggyBac vector containing this same gene in the left-
ward orientation (vector B in Column A, Fig. 5). Similarly,
vectors encoding GalT, ST6GalI, and ST3GalIII genes in
the rightward orientation induced about 8X, 8X, and 3X
more activity, respectively, than vectors encoding these
genes in the leftward orientation (Fig. 5, columns A-B).
This effect was not restricted to mammalian glycosyltrans-
ferase genes, as piggyBac vectors containing SAS and CMP-
SAS genes in the rightward orientation induced about 3X
and 4X higher sialic acid and CMP-sialic acid contents,
respectively, than those containing these same genes in
the leftward orientation (Fig. 5, Column C). Furthermore,
this effect was not restricted to the dual constitutive con-
trol element (ie1-hr5-ie1), as it also was observed with pig-
gyBac vectors containing heterologous gene pairs under
the control of the inducible control element (PCMVmin-
TetO7-PCMVmin; compare bars B and D in Fig. 6). These
results revealed that the new piggyBac vectors constructed
in this study exhibited a strong position effect, in which
heterologous genes cloned in the rightward orientation
were uniformly induced at higher levels than the same
genes cloned in the leftward orientation, irrespective of
the identity of the heterologous gene or control element
used for its expression.
The position effect does not reflect antisense down-
regulation of the leftward genes
One hypothetical explanation for this striking position
effect was that the piggyBac transposase promoter located
in the 5'-TRD of the piggyBac  vectors, which is down-
stream and in opposite orientation of the leftward genes,
produced antisense transcripts that down-regulated
expression of these leftward genes. Experiments were
designed and performed to address this possibility. If the
position effect observed with the new piggyBac  vectors
reflected down-regulation of the leftward genes by anti-
sense transcription originating in the downstream 5'-TRD,
the introduction of a polyadenylation signal between the
two transcription units should reduce or eliminate this
effect. The new polyadenylation signal would be expected
to direct cleavage and polyadenylation of transcripts orig-
inating in the 5'-TRD, resulting in transcripts that would
not overlap with the downstream region encoding the
leftward heterologous gene in the opposite orientation.
Thus, the newly inserted polyadenylation signal would be
expected to block any potential negative effect arising
from an antisense RNA mechanism. The two piggyBac vec-
tors encoding constitutive or inducible GalT genes in the
leftward orientation (Fig. 6E and 6F) were used as targets
for the insertion of a BGHpolyA signal in the appropriate
orientation downstream of the 5'-TRD. Subsequently,
transient expression assays were performed to compare
the GalT expression levels induced by these new piggyBac
derivatives with those induced by the original vectors
encoding the constitutive or inducible GalT genes in
either the rightward or leftward orientations. The results
confirmed that the original vectors encoding the right-
ward (Fig. 6, vectors C and D) GalT genes induced higher
levels of GalT activity than those encoding the leftward
(Fig. 6, vectors A and B) GalT genes. The results also
showed that insertion of the BGHpolyA signal failed to
reduce or eliminate this position effect, irrespective of
promoter type (Fig. 6, vectors E and F).BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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Another way to reduce or eliminate a potential negative
effect of antisense transcription on leftward gene expres-
sion was to delete the 5'-TRD internal domain sequence,
which contains the transposase transcriptional initiation
region [4]. Thus, this region was deleted from piggyBac
vectors containing the constitutive GalT gene in the left-
ward or rightward orientations (Fig. 7, vectors B and D)
and GalT expression levels induced by these new deriva-
tives were compared to those induced by controls contain-
ing the intact promoter. Interestingly, the piggyBac vectors
with the transposase promoter deletion induced about
20-30% higher GalT activity than the controls, irrespective
of the orientation of the GalT gene (Fig. 7). However, the
promoter deletion failed to reduce or eliminate the
observed position effect, as the levels of GalT expression
observed with the leftward gene remained lower than
those observed with the rightward gene, even when the 5'-
TRD internal domain was deleted.
Together, the results of the transient expression assays per-
formed using the piggyBac vectors with BGHpolyA inser-
tions or transposase promoter deletions strongly
suggested that antisense transcription originating in the
piggyBac transposase promoter within the 5'-TRD is not
responsible for the observed position effect.
piggyBac vector constructions (continued) Figure 2
piggyBac vector constructions (continued). A. PCR 
amplification of the fluorescent eye color markers. B. Assem-
bly of intermediate plasmids that include the dual constitutive 
transcriptional control element, fluorescent eye color mark-
ers, and appropriate polyadenylation sites.
piggyBac vector constructions Figure 1
piggyBac vector constructions. A. Construction of the 
dual constitutive transcriptional control element. B. Addition 
of a polyadenylation signal.BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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piggyBac vector constructions (continued) Figure 3
piggyBac vector constructions (continued). PCR amplification of six genes encoding mammalian glycosylation enzymes 
and their subsequent insertion into the key intermediate plasmids to produce the constitutive (ie1-hr5-ie1) dual piggyBac vec-
tors.BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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The position effect reflects activation of the rightward 
genes
Another hypothetical explanation for the position effect
observed with the new piggyBac  vectors was that gene
expression in the rightward direction is somehow acti-
vated relative to gene expression in the leftward direction.
A preliminary clue indicating that this might be the correct
hypothesis was obtained by comparing the levels of
expression induced by piggyBac  vectors containing the
rightward or leftward heterologous genes with those
induced by precursor (pCRBluntII-TOPO) plasmids con-
taining the same genes outside the context of piggyBac
(Fig. 8). The results of these assays revealed that the levels
of activity induced by the precursor plasmids were more
similar to those induced by the piggyBac vectors contain-
ing the leftward than the rightward heterologous genes.
The activity levels induced by the piggyBac vectors contain-
ing the heterologous genes in the rightward orientation
were significantly (5X to over 35X) higher. Thus, together
with our previous results, these results suggested that the
position effect observed with our new piggyBac  vectors
results from the activated expression of heterologous
genes cloned in the rightward orientation, irrespective of
the transcriptional control element. Additional experi-
ments were designed to further examine this possibility.
A previously unrecognized activator sequence in the 
piggyBac 3'-TRD
The most obvious source of a sequence that might be able
to activate expression of the rightward genes in our new
piggyBac  vectors was the downstream 3'-TRD, which
includes the piggyBac  3' terminal repeat and a 172 bp
internal domain sequence with an 83% AT content [4,18].
The 3'-TRD internal domain sequence (3'-TRDID) was tar-
geted for further analysis. A PCR-amplified copy of this
sequence was inserted downstream and in the same orien-
tation with respect to the leftward facing constitutive and
inducible genes into a selected subset of the piggyBac vec-
tors produced in this study (Fig. 9, Columns A, B and C,
constructs C and E). The enzyme activities induced by
these new piggyBac derivatives, which contained the left-
ward-facing heterologous genes plus the 3'-TRDID insert,
were then compared to those induced by the original pig-
gyBac vectors containing the same heterologous genes in
either orientation, but without the additional 3'-TRDID
insert. The results of these assays showed that insertion of
the putative activator sequence downstream of the left-
ward-oriented genes eliminated the position effect, irre-
spective of the identity of the heterologous gene or
promoter type (Fig. 9).
Additional transient expression assays were performed to
compare the influence of inserting a single copy of the 3'-
TRDID sequence into the constitutive and inducible piggy-
Bac derivatives downstream and in the same (Fig. 10, vec-
piggyBac vector constructions (continued) Figure 4
piggyBac vector constructions (continued). Replacement of the constitutive transcriptional control element to produce 
the inducible (PCMVmin-TetO7-PCMVmin) dual piggyBac vectors.BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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tors C and F) or opposite (Fig. 10, vectors D and G)
orientation, relative to the leftward-facing GalT gene.
Constitutive and inducible piggyBac vectors containing the
GalT gene in the leftward orientation with no downstream
copy of the 3'-TRDID sequence (Fig. 10, vectors B and E)
were used as negative controls and a constitutive piggyBac
vector containing the GalT gene in the rightward orienta-
tion (Fig. 10, vector A) was used as a positive control. The
results of these assays showed that addition of the 3'-
TRDID sequence downstream of the leftward facing GalT
genes induced higher activity levels, irrespective of its ori-
entation, relative to the negative controls lacking the
downstream 3'-TRDID sequence (Fig. 10). This effect was
not completely orientation-independent, however, as the
piggyBac vectors containing the 3'-TRDID sequence in the
same orientation as the leftward facing GalT gene (vectors
C and F) induced higher levels of GalT activity than those
containing the 3'-TRDID sequence in the opposite orienta-
tion (vectors D and G).
Functionality of dual piggyBac vectors in transgenic insects
Finally, we examined the insect transformation functions
of two representative members of our large new set of dual
piggyBac vectors, one designed for constitutive expression
and the other designed for inducible expression of heter-
ologous gene pairs. In the first experiment, D. melanogaster
was transformed with one of our dual piggyBac vectors
encoding SAS and CMP-SAS under the control of the dual
constitutive transcriptional control element. Five trans-
formed fly lines were then fed with N-acetylman-
nosamine, larval homogenates were prepared, and sialic
acid and CMP-sialic acid contents were assayed, as
described in Methods. The results showed that this repre-
sentative piggyBac vector could, indeed, be used to trans-
form an insect for constitutive expression of this
Expression levels induced by constitutive piggyBac vectors Figure 5
Expression levels induced by constitutive piggyBac vectors. The genetic structures of the different constitutive piggyBac 
vectors assayed in this experiment, with the differences in orientation of the heterologous genes indicated by A and B, are 
shown above the plots in Columns A, B, and C. Column A shows the GlcNAcTII (upper plot) and GalT (lower plot) activities 
induced by the vectors encoding these enzymes in orientations A and B. Column B shows the ST6GalI (upper plot) and 
ST3GalIII (lower plot) activities induced by the vectors encoding these enzymes in orientations A and B. Column C shows the 
sialic acid (upper plot) and CMP-sialic acid (lower plot) levels induced by the vectors encoding these enzymes in orientations A 
and B. The background levels in each assay were determined using extracts of mock-transfected Sf9 cells and are shown by the 
bars labeled "None". SfSWT3 and CHO refer to extracts of a transgenic insect cell line [15, 16] or Chinese hamster ovary 
cells, which served as positive controls for these assays.BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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heterologous gene pair, as the transformed fly lines all had
high levels of both free sialic acid and CMP-sialic acid
than the wild type control (Fig. 11). In the second experi-
ment, D. melanogaster was transformed with one of our
dual piggyBac vectors encoding GalT and GnTII under the
control of the dual inducible transcriptional control ele-
ment. Five transformed fly lines were then fed with or
without doxycycline, larval homogenates were prepared,
and GalT and GnTII activities were assayed, as described
in Methods. The results showed that all of the fly lines had
higher levels of GnTII activity and all but one had higher
levels of GalT activity than the wild type controls (Fig. 12),
which indicated that the inducible control element is not
tightly regulated in transgenic insects. However, doxycy-
cline induced GnTII and GalT activities in 4/5 and 3/5
lines examined, respectively. Thus, while undetermined
Effects of introducing BGHPolyA to arrest potential anti- sense transcription Figure 6
Effects of introducing BGHPolyA to arrest potential 
antisense transcription. The genetic structures of the dif-
ferent piggyBac vectors assayed in this experiment (A-F) are 
shown at the top, with the dual constitutive (ie1-hr5-ie1) 
transcriptional control elements indicated by open boxes, 
the dual inducible (PCMVmin-TetO7-PCMVmin) transcriptional 
control element indicated by horizontally striped boxes, the 
orientations of the various heterologous genes shown, and 
the newly introduced BGHPolyA site marked with a star. 
The rightward-oriented arrow marked with a question mark 
depicts the hypothesis that antisense transcription originating 
in the 5'-TRD region could down-regulate expression of the 
leftward-facing heterologous genes. The plot shows the rela-
tive GalT activity levels induced by each of the indicated pig-
gyBac vectors, together with the background levels 
determined using extracts of mock-transfected Sf9 cells 
(None).
Effects of deleting the transposase transcriptional control  element in the 5'-TRD region Figure 7
Effects of deleting the transposase transcriptional 
control element in the 5'-TRD region. The genetic 
structures of the constitutive piggyBac vectors assayed in this 
experiment (A-D) are shown at the top, with the orienta-
tions of the various heterologous genes shown, and the 
transposase promoter deletion indicated. The rightward-ori-
ented arrow marked with a question mark depicts the 
hypothesis that antisense transcription originating in the 5'-
TRD region could down-regulate expression of the leftward-
facing heterologous genes. The plot shows the relative GalT 
activity levels induced by each of the indicated piggyBac vec-
tors, together with the background levels determined using 
extracts of mock-transfected Sf9 cells (None).BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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factors, such as the nature of the integration site, can influ-
ence its function, these data show that the representative
dual piggyBac vector designed for inducible expression of
heterologous gene pairs was functional in transgenic
insects.
Conclusion
The initial purpose of this study was to produce and char-
acterize new piggyBac vectors that could be used to transfer
heterologous gene pairs into the genome of a target organ-
ism in either constitutively- or inducibly-expressible
forms. Functional characterization of these new vectors
revealed an unexpected position effect that was independ-
ent of the identity of the heterologous gene or the tran-
scriptional control element. In the process of performing
experiments designed to help us understand the underly-
ing reason for this position effect, we discovered a previ-
ously unrecognized cis-activating element derived from
the internal domain of the 3' terminal repeat in the piggy-
Bac transposable element. This element appears to func-
tion as an enhancer element, as it stimulates heterologous
gene expression in an essentially orientation-independent
fashion, albeit to different levels. However, formal defini-
tion of this element as an enhancer would require addi-
tional characterization to determine if it can function
autonomously in a position- and orientation-independ-
ent fashion.
The discovery of this element will be of general interest to
investigators who are aware of piggyBac and its widespread
and growing applications as a transformation vector. In
addition, given their ability to provide constitutive or
inducible expression of heterologous gene pairs, the large
set of new dual piggyBac vectors described in this study
will be of interest to investigators who need to introduce
multiple genes into a single target organism.
Methods
PCR amplification
High fidelity KOD  (Novagen, Madison, WI) DNA
polymerase was used as described in the manufacturer's
manual. Briefly, 50 μL PCR reactions consisted of 5 μL of
10X KOD DNA polymerase buffer, 5 μL of dNTP mix (10
mM each), 2 μL of 25 mM MgCl2, 0.5 μL of KOD DNA
polymerase, 0.5 μL of each primer (50 μM), 10 μL of tem-
plate, and 26.5 μL of H2O. The fragments were amplified
after an initial denaturation step at 95°C for 2 min using
30 cycles of 15 sec at 98°C, 30 sec at appropriate primer
annealing temperatures, and 1.5 min at 72°C. The desired
fragments were purified by agarose gel fractionation
before being cloned into either pCRBluntII-TOPO (Invit-
rogen, Carlsbad, CA) or pCR2.1-TOPO (Invitrogen), and
sequence-verified clones were used to assemble all of the
final constructs described in this study.
Molecular cloning
General molecular cloning methods were performed as
described in reference [19]. PCR products were cloned
into pCRBluntII-TOPO (Invitrogen) or pCR2.1-TOPO as
described by the manufacturer. All restriction endonucle-
ases were purchased from New England Biolabs, Inc. (Bev-
erly, MA).
Construction of piggyBac vectors for constitutive 
expression of heterologous gene pairs
A transcriptional control element consisting of back-to-
back baculovirus ie1 promoters separated by a baculovirus
hr5 enhancer was constructed in a series of steps (Fig. 1, 2,
3, 4), which began with PCR amplification of DNA frag-
ments termed hr5IE1R and IE1L using pAcP(+)IE1TV3
[20] as the template and Hr5IE1Rsense plus Hr5IE1Ranti
or IE1Lsense plus IE1Lanti as the primers (Table 1 and Fig.
1A). Each of the resulting amplification products was
cloned into pCRBluntII-TOPO (Invitrogen) and error-free
clones identified by restriction mapping and DNA
sequencing were designated pHr5IE1R-TOPO.1 and
pIE1L-TOPO.1. The desired "ie1-hr5-ie1" dual constitutive
transcriptional control element was subsequently assem-
bled by excising the IEL fragment from pIE1L-TOPO.1
with XbaI and KpnI and subcloning it into the SpeI and
Expression levels induced by precursor plasmids and consti- tutive piggyBac vectors Figure 8
Expression levels induced by precursor plasmids and 
constitutive piggyBac vectors. The plot shows the levels 
of enzyme activity induced by precursor plasmids or piggyBac 
vectors encoding the six heterologous genes of interest 
under the control of the constitutive transcriptional control 
element. Black bars show the levels obtained with the pre-
cursor plasmids, white bars show the levels obtained with 
the piggyBac vectors containing heterologous genes in the 
rightward orientation, and gray bars show the levels obtained 
with the piggyBac vectors containing heterologous genes in 
the leftward orientation.BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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KpnI sites of pHr5IE1R-TOPO.1, which yielded pDIE1-
TOPO.1. The XbaI site in pDIE1-TOPO.1 was then ablated
by XbaI digestion, Klenow repair, and re-ligation to pro-
duce pDIE1-TOPO.2.
In a parallel set of cloning reactions (Fig. 1B), a DNA frag-
ment containing the bovine growth hormone polyade-
nylation signal [21] was PCR amplified using pCR3.1
(Invitrogen) as the template and BGHsense and BGHanti
as the primers (Table 1). The product was cloned into
pCRBluntII-TOPO and an error-free clone identified by
restriction mapping and DNA sequencing was designated
pBGHpolyA-TOPO.1. The BGHpolyA fragment was then
excised from pBGHpolyA-TOPO.1 with ApaI and BsaI and
subcloned into the same sites of pDIE1-TOPO.2 to pro-
duce pDIE1-TOPO.3.
A third parallel set of cloning reactions (Fig. 2A) was per-
formed to place three different fluorescent marker genes
under the transcriptional control of the eye-specific pro-
moter, 3xP3 [22], for subsequent insertion into pDIE1-
TOPO.3. First, the 3xP3 promoter fragment was PCR
amplified using pBSII-LTR1.1k-ECFP [18] as the template
and 3xP3sense plus 3xP3anti as the primers (Table 1). The
product was cloned into pCRBluntII-TOPO, an error-free
clone designated p3xP3-TOPO.1 was identified by restric-
tion mapping and DNA sequencing, and then the ApaI
and BsaI fragment of pBGHpolyA-TOPO.1, which con-
tains the BGH polyA signal, was inserted at the corre-
sponding sites of this plasmid to produce p3xP3-TOPO.2.
Subsequently, each fluorescent marker gene of interest,
including DsRed1, EGFP, and EYFP, was individually
PCR-amplified using p3xP3-DsRed1-ORF (Li and Fraser,
unpublished), pBSII-LTR1.1k-ECFP [18], and pBSII-
LTR1.1k-EYFP [18] as the templates and DsRed1sense
plus DsRed1anti, EGFPsense plus EGFPanti, and
EYFPsense plus EYFPanti (Table 1) as the primers, respec-
tively. Each individual PCR product was cloned into
Effects of introducing a copy of the 3'-TRD internal domain on leftward gene expression Figure 9
Effects of introducing a copy of the 3'-TRD internal domain on leftward gene expression. The genetic structures of 
the different piggyBac vectors assayed in this experiment (A-E) are shown above the plots in Columns A, B, and C. The dual 
constitutive (ie1-hr5-ie1) transcriptional control element is indicated by open boxes, the dual inducible (PCMVmin-TetO7-PCMVmin) 
transcriptional control element is indicated by horizontally striped boxes, the orientations of the various heterologous genes 
are shown, and the new 3'-TRD internal domain sequence introduced in the 5'-TRD region is marked with an cross-hatched 
oval and an arrow to show its orientation. The plot in Column A shows the GalT activities induced by the various GalT-encod-
ing vectors A-E. The plot in Column B shows the ST6GalI activities induced by the various ST6GalI-encoding vectors A-E. The 
plot in Column C shows the amounts of CMP-sialic acid produced by the various CMP-SAS-encoding vectors A-E. The back-
ground levels in each assay were determined using extracts of mock-transfected Sf9 cells and are shown by the bars labeled 
"None".BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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pCRBluntII-TOPO to produce pDsRed1-TOPO.1, pECFP-
TOPO.1, and pEYFP-TOPO.1, respectively, and error-free
clones were identified by restriction mapping and DNA
sequencing. Finally, each individual marker was excised
with NheI and ApaI and subcloned into the corresponding
sites of p3xP3-TOPO.2 to produce p3xP3DsRed1-
TOPO.2, p3xP3ECFP-TOPO.2, and p3xP3EYFP-TOPO.2.
The eye color markers were subsequently incorporated
into the intermediate plasmids containing the dual consti-
tutive  ie1-hr5-ie1  transcriptional control element (Fig.
2B). The red, cyan, and yellow fluorescent protein markers
were excised by digesting 3xP3DsRed1, 3xP3ECFP, and
3xP3EYFY with BglII and BsaI and each was individually
subcloned into the BamHI and BsaI sites of pDIE1-
TOPO.3 to produce pDIE1DsRed1-TOPO.3, pDIE1ECFP-
TOPO.3, and pDIE1EYFP-TOPO.3, respectively. Subse-
quently, the KpnI-HindIII fragment from pBGHpolyA-
TOPO.1 was subcloned into the corresponding sites
downstream of the leftward ie1 promoter in each of these
plasmids. This yielded key intermediate plasmids desig-
nated pDIE1DsRed1-TOPO.4, pDIE1ECFP-TOPO.4, and
pDIE1EYFP-TOPO.4, each of which included the ie1-hr5-
ie1 regulatory element for constitutive expression of heter-
ologous gene pairs, unique restriction sites downstream of
both promoters for insertion of the heterologous genes of
interest, and a fluorescent eye color marker for the identi-
fication of transgenic offspring.
For the purposes of a project that will be described else-
where, we subsequently inserted six heterologous mam-
malian genes encoding enzymes involved in protein N-
glycosylation into the three key intermediate plasmids
described above (Fig. 3). A human N-acetylglucosaminyl-
transferase II (GnTII; [23]) coding sequence was PCR
amplified using pHG30 [23] as the template and human-
GlcNAcTIIsense plus humanGlcNAcTIIanti (Table1) as
the primers. Similarly, the sequence encoding bovine
β1,4-galactosyltransferase (GalT; [24]) was amplified
using pBSKS-β4GalT as the template and bovineβ
4GalTsense plus bovineβ4GalTanti (Table 1) as the prim-
ers, the sequence encoding a rat α2,6-sialyltransferase
(ST6GalI; [25]) was amplified using pIE1HR3ST6Δcys
[26] as the template and ratST6sense plus ratST6anti
(Table 1) as the primers, the sequence encoding a mouse
α2,3-sialyltransferase (ST3GalIII; [27,28]) was amplified
using pST3GalIII [28] as the template and mouseST3sense
plus mouseST3anti (Table 1) as the primers, the sequence
encoding mouse sialic acid synthase (SAS; [29]) was
amplified using p64KDIE1TV1/SAS/CMP-SAS [30] as the
template and mouseSASsense plus mouseSASanti as the
primers, and the sequence encoding mouse CMP-sialic
acid synthetase (CMP-SAS;[31]) was amplified using
p64KDIE1TV1/SAS/CMP-SAS [30] as the template and
mouseCMP.SASsense plus mouseCMP.SASanti (Table 1)
as the primers. Except for ST3GalIII, each amplification
product was cloned into pCRBluntII-TOPO (Invitrogen)
and error-free clones were identified by DNA sequencing.
The cis-activating function of the 3'-TRD internal domain  sequence is essentially orientation-independent Figure 10
The cis-activating function of the 3'-TRD internal 
domain sequence is essentially orientation-independ-
ent. The genetic structures of the different piggyBac vectors 
assayed in this experiment (A-G) are shown above the plot. 
The dual constitutive (ie1-hr5-ie1) transcriptional control ele-
ment is indicated by open boxes, the dual inducible (PCMVmin-
TetO7-PCMVmin) transcriptional control element is indicated 
by horizontally striped boxes, the orientations of the various 
heterologous genes are shown, and the new 3'-TRD internal 
domain sequence introduced into the 5'-TRD region is 
marked with an cross-hatched oval and an arrow to show its 
orientation. The plot shows the relative levels of GalT activ-
ity induced by each of the indicated piggyBac vectors, 
together with the background levels determined using 
extracts of mock-transfected Sf9 cells (None).BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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The ST3GalIII product had two single nucleotide substitu-
tions at amino acid positions 80 (phenylalanine to serine)
and 294 (glycine to cysteine), which were corrected by
site-directed mutagenesis before subcloning, and the cor-
rected amplification product was designated ST3.3m. Sub-
sequently, PmeI-SpeI fragments encoding GnTII, ST6GalI,
or SAS (designated as "Glyco-A" genes in Fig. 3) were
inserted at the corresponding sites downstream of the left-
ward ie1  promoters and NruI-NotI fragments encoding
GalT, ST3.3m, or CMP.SAS ("Glyco-B" genes in Fig. 3)
were inserted at the corresponding sites located down-
stream of the rightward ie1  promoters in the relevant
intermediate plasmids. This yielded three derivatives
termed pDIE1-GnTII/GalT-DsRed1-TOPO.4, pDIE1-
ST6.1/ST3.3-ECFP-TOPO.4, and pDIE1-SAS/CMP.SAS-
EYFP-TOPO.4. Finally, the expression cassettes were
excised from these derivatives with XbaI and each was
individually subcloned into the corresponding site of the
piggyBac vector, pXLBacII [18]. This final step yielded six
piggyBac  vectors, designated pXLBacII-GnTII/GalT-
DsRed1, pXLBacII-ST6.1/ST3.3-ECFP, and pXLBacII-SAS/
CMP.SAS-EYFP, which contained the three different con-
stitutive expression cassettes in each of the two different
orientations. The three vectors containing the expression
cassettes with the "Glyco-A" genes facing rightward (pXL-
BacII-GalT/GnTII-DsRed1.A cl 57, pXLBacII-ST3.3/ST6.1-
ECFP.A cl 29, and pXLBacII-CMP.SAS/SAS-EYFP.A cl 42)
were designated as vector "Set 1" and those containing
these same genes facing leftward (pXLBacII-GnTII/GalT-
DsRed1.B cl 1, pXLBacII-ST6.1/ST3.3-ECFP.B cl 21, and
pXLBacII-SAS/CMP.SAS-EYFP.B cl 1) were designated as
vector "Set 2" (Fig. 3).
Construction of piggyBac vectors for inducible expression 
of heterologous gene pairs
A transcriptional control element consisting of back-to-
back minimal cytomegalovirus immediate early promot-
ers (PCMVmin) separated by a tetracycline-inducible opera-
tor (TetO7; [32]) was constructed in several steps (Fig. 4).
First, copies of the PCMVmin element and the fused TetO7-
PCMVmin element were individually PCR amplified using
pTRE2hyg-luc (BD Biosciences, Palo Alto, CA) as the tem-
plate and HpaCMV plus NruCMV or HpaTetO plus
PmeCMV as the primers (Table 1). Each of the resulting
DNA fragments was cloned into pCR2.1-TOPO (Invitro-
gen) and error-free clones identified by restriction map-
ping and DNA sequencing were designated pCR2.1-
HpaCMVNru and pCR2.1-PmeTetO, respectively. Subse-
quently, the PCMVmin fragment was excised from pCR2.1-
HpaCMVNru with HpaI and BamHI and subcloned into
the corresponding sites of pCR2.1-PmeTetO to produce
pCR2.1-NruTetOPme, which contained the fully assem-
bled control element consisting of back-to-back copies of
the CMV promoter separated by the tetracycline-inducible
operator. This "PCMVmin-TetO7-PCMVmin" regulatory ele-
ment was then excised from pCR2.1-NruTetOPme with
NruI and PmeI and used to replace the "ie1-hr5-ie1" con-
trol element in a subset of the dual constitutive piggyBac
vectors from Sets 1 and 2, which were described above.
This yielded two new sets of piggyBac vectors (Sets 3 and
4), which were designated pXLBacII-TetO1.GalT/GnTII-
DsRed.A cl 3, pXLBacII-TetO1.CMP-SAS/SAS-EYFP.A cl
35, pXLBacII-TetO1.GnTII/GalT-DsRed.B cl 18, and pXL-
BacII-TetO1.ST6.1/ST3.3-ECFP.B cl 30. These vectors
encoded the indicated heterologous gene pairs under the
control of the tetracycline inducible transcriptional con-
trol element, as well as the various fluorescent eye color
markers described above.
A representative dual, constitutive piggyBac vector is func- tional as an insect transformation vector Figure 11
A representative dual, constitutive piggyBac vector is 
functional as an insect transformation vector. D. mela-
nogaster was transformed with pXLBacII-CMP-SAS/SAS-
EYFP.LTR-F cl 25, which encodes CMP-SAS and SAS under 
the control of the ie1-hr5-ie1 dual constitutivetranscriptional 
control element, and several transgenic lines were isolated, 
as described in Methods. After being cultured in the pres-
ence of N-acetylmannosamine, larvae from five transgenic 
lines or wild type were extracted and the extracts were used 
to measure total CMP-sialic acid (A) and sialic acid (B) con-
tents, as described in Methods. Each bar represents the aver-
age results obtained using duplicate samples of extracts from 
groups of larvae obtained from each fly line.BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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Construction of BGHpolyA-modified piggyBac vectors
Two of the piggyBac vectors in Set 1 described above were
further modified by the insertion of an additional BGH-
polyA signal downstream of the 5'-TRD. A DNA fragment
containing the BGH polyA signal was excised from pBGH-
polyA-TOPO.1 (Fig. 1B) with ApaI and BamHI, the ends
were repaired with Klenow, and the resulting blunt ended
DNA fragment was inserted into the Klenow-repaired
BglII site in the internal domain in the 5'-TRDs of pXL-
BacII-GalT/GnTII-DsRed1.A cl57 and pXLBacII-
TetO1.GalT/GnTII-DsRed1.A cl 3 (Fig. 4 and Fig. 6, top).
The two desired BGHpolyA-modified vectors, which had
the additional BGHpolyA signal oriented in the same
direction as the remnant piggyBac promoter element in the
5'-TRD (vectors E and F in Fig. 6, top), were identified by
colony PCR with the primer pair BGHpolyASeq1 plus
BGHsense (Table 1) and DNA sequencing. These two new
vectors were designated pXLBacII-GalT/GnTII-
DsRed1.BGH.A cl 2 and pXLBacII-TetO1.GalT/GnTII-
DsRed1.BGH.A cl 20.
Construction of piggyBac vectors lacking the transposase 
promoter
Two additional piggyBac vectors lacking the piggyBac tran-
scription start region (TSR) in the 5'-TRD [4,18] were con-
structed by digesting pXLBacII with HindIII and SphI to
delete nucleotides 1146-1429, repairing the ends with
Klenow, and religating to produce a derivative designated
pXLBacIIΔTSR. Subsequently, the constitutive GnTII/GalT
expression cassette was inserted at a unique XbaI site and
clones containing the insert in either orientation were
identified by restriction mapping and designated pXL-
BacIIΔTSR-GalT/GnTII/-DsRed1.A cl 16 and pXLBacI-
IΔTSR-GnTII/GalT-DsRed1.B cl 13.
Construction of 3'-TRDID-modified piggyBac vectors
The final piggyBac vectors constructed for this study were
designed to have an additional copy of a highly AT-rich
(83% A+T), putative transcriptional activator derived
from the piggyBac 3' internal domain [4,18]. A DNA frag-
ment containing nucleotides 789-986 of pXLBacII, which
contained this putative transcriptional activator, was pro-
duced by PCR with pXLBacII as the template and 5'LTRac-
tivator plus 3'LTRactivator as the primers (Table 1). The
resulting PCR fragment was cloned into the Klenow-
repaired BglII site downstream of the leftward-facing GalT
gene in pXLBacII-GalT/GnTII-DsRed1.A cl 57. Derivatives
containing the insert in either the forward or reverse ori-
entation, with respect to the GalT gene, were identified by
restriction mapping and DNA sequencing and designated
pXLBacII-GalT/GnTII-DsRed1.LTR.F cl 16 and pXLBacII-
GalT/GnTII-DsRed1.LTR.R cl 25, respectively. Analogous
derivatives of the inducible piggyBac  vectors were pro-
duced by inserting the blunt-ended DNA fragment con-
taining the putative transcriptional activator sequence
A representative dual, inducible piggyBac vector is functional  as an insect transformation vector Figure 12
A representative dual, inducible piggyBac vector is 
functional as an insect transformation vector. D. mela-
nogaster was transformed with pXLBacII-TetO1.GalT/GnTII-
DsRed.A cl 3, which encodes GalT and GnTII under the con-
trol of the PCMVmin-TetO7-PCMVmin dual tetracycline-inducible 
transcriptional element, and several transgenic lines were 
isolated, as described in Methods. After being cultured in the 
presence or absence of doxycycline, larvae from five trans-
genic lines or wild type were extracted and the extracts 
were used to measure GnTII (A) and GalT (B) activities, as 
described in Methods. Each bar represents the average 
results obtained using duplicate samples of extracts from 
groups of larvae obtained from each fly line. The error bars 
show the standard deviations and the asterisks mark the lines 
that had statistically significant (p = 0.05) differences in 
enzyme activity levels measured in the absence and presence 
of doxycycline. The statistical analysis represents the results 
of one-tailed student's t-tests with the assumption of equal 
variances, which was checked by comparing the ratio of the 
variances with the appropriate F value on a table of F values 
for p = 0.05. The equal variance assumption failed for the 
GnTII (panel A) assays on lines #13 and #14 and for the GalT 
assay on line #13. Thus, those t-tests were repeated assum-
ing unequal variance and these results are reported. The p 
values obtained for the GnTII assays (A) were #1 (0.26), #7 
(0.01), #8 (0.01), #13 (0.05), and #14 (0.10). The p values 
obtained for the GalT assays (B) were #1 (0.00), #7 (0.01), 
#8 (0.19), #13 (0.03), and #14 (0.27).BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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into the Klenow-repaired BglII sites of pXLBacII-
TetO1.GalT/GnTII-DsRed1.A cl 3 and identifying clones
containing the insert in either the forward or reverse ori-
entation with respect to the GalT gene, which were desig-
nated pXLBacII-TetO1.GalT/GnTII-DsRed1.LTR.F cl 23
and pXLBacII-TetO1.GalT/GnTII-DsRed1.LTR.R cl 24,
respectively. We also cloned this same putative transcrip-
tional activator fragment in the forward orientation, with
respect to the leftward-facing CMP-SAS and ST6GalI
genes, using the Klenow-repaired BglII sites of pXLBacII-
CMP-SAS/SAS-EYFP.A cl 42 and pXLBacII-TetO1.CMP-
SAS/SAS-EYFP.A cl 35 and the Klenow-repaired SalI sites
of pXLBacII-ST6.1/ST3.3-ECFP.B cl 1 and pXLBacII-
TetO1.ST6.1/ST3.3-ECFP.A cl30, respectively. This yielded
pXLBacII-ST6.1/ST3.3-ECFP.LTR.F cl 10, pXLBacII-
TetO1.ST6.1/ST3.3-ECFP.LTR.F cl 11, pXLBacII-CMP-
SAS/SAS-EYFP.LTR-F cl 25, and pXLBacII-TetO1.CMP-
SAS/SAS-EYFP.LTR-F cl 12, which completed the set of 3'-
TRD-modified piggyBac vectors required for our studies.
The sequence of the newly inserted putative activator frag-
ment was directly confirmed by DNA sequencing of each
of the 3'-TRDID-modified piggyBac vectors.
Glycosyltransferase assays
Cultures containing 2 × 106 Sf9 cells were transfected with
10 μg of the relevant plasmid DNA(s) using a modified
calcium phosphate precipitation method [33]. At 24 h
post-transfection, the cells were washed once with ice-
cold Tris-buffered saline (TBS; 50 mM Tris.Cl, pH7.5, and
150 mM NaCl) and once with the buffer to be used for the
relevant glycosyltransferase activity assay. The cells were
then extracted with the same glycosyltransferase buffer
supplemented with 1% (v/v) Triton X-100 (Sigma-
Aldrich, St. Louis, MO) and the extracts were frozen prior
to being used for the glycosyltransferase assays. The tetra-
cycline-inducible piggyBac  vectors were assayed using a
slightly different method in which Sf9 cells were co-trans-
fected with the vector of interest in the presence of a
Table 1: Oligonucleotides used in this study
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helper plasmid, pBSK.Hr5IE1.rtTAM2.SV40-1.1k.ITR-
3xP3-EGFP, which encodes the mutant repressor needed
to induce transcription in the presence of tetracycline. At
12 h post-transfection, these cell cultures were treated
with fresh growth medium containing 1.0 μg/mL doxycy-
cline (BD Biosciences) and they were extracted 24 h later.
The GnTII, GalT, ST6, and ST3 enzyme activity assays were
performed as described previously [16,26,28,34]. The cell
extraction and enzyme assay buffers used for these exper-
iments were GnTII buffer [100 mM MES, pH 6.1, 100 mM
NaCl and 1% (v/v) Triton X-100], GalT buffer (10 mM
HEPES, pH 7.4, 140 mM NaCl, 20 mM MnCl2, and 0.5%
Nonidet P-40), ST6 buffer (50 mM Na2HPO4, pH 7.5, 100
mM NaCl, 10 mM MgCl2, and 1.5% Triton CF-54), and
ST3 buffer (100 mM sodium cacodylate, pH 6.4, 10 mM
MgCl2, 2 mM CaCl2, and 1.5% Triton CF-54). Cells were
washed with these buffers minus the detergents and
extracted with these buffers plus the detergents, as
described above, and the extracts were frozen at -85°C.
Prior to performing the assays, the cell extracts were
thawed, clarified at 1,000 × g for 5 min at 4°C in a micro-
centrifuge, and total protein concentrations were deter-
mined using a commercial bicinchoninic acid assay
(Pierce, Rockford, IL) with BSA as the standard. Duplicate
samples of each extract, containing 100 μg of total pro-
tein, were then incubated at 37°C for 1 h with donor and
acceptor substrates in the appropriate buffers and supple-
ments. The final GnTII assay reaction contained 67 mM
MES (pH 6.1), 67 mM NaCl, 15 mM MnCl2, 6.7 mM
AMP, 133 mM N-acetylglucosamine, 0.0833 mM
Manα1,6(GlcNAcβ1,2Manα1,3)-Manβ-octyl (Toronto
Research Chemicals, Ontario, Canada), and 0.9 μCi of
uridine diphosphate [6-3H]-N-acetylglucosamine (60 Ci/
mmol; American Radiolabeled Chemicals, Inc., St. Louis,
MO). The final GalT assay reaction contained 0.3 μCi of
uridine diphosphate [6-3H]-galactose (9.1 Ci/mmol;
American Radiolabeled Chemicals) and 830 ug/mL of
ovalbumin (Sigma-Aldrich) in the GalT buffer described
above. The final ST6GalI and ST3GalIII assay reactions
contained 0.3 μCi of cytidine 5'-monophosphate [6-14C]
sialic acid (20 Ci/mmol; American Radiolabeled Chemi-
cals) and 310 ug/mL of asialofetuin (Sigma-Aldrich). After
the 1 h incubation period, each reaction was quenched by
dilution with ice cold water and radiolabeled GnTII prod-
ucts were collected by reverse phase chromatography with
SepPak C18 cartridges (Millipore, Bedford, MA), while
radiolabeled GalT, ST6GalI, and ST3GalIII products were
collected by TCA precipitation onto Whatman GF/D glass
microfibre filters (Whatman Inc., Florham Park, N.J.). Fol-
lowing elution, the amounts of radioactivity transferred to
each donor substrate in duplicate reactions were meas-
ured with a Model LS-6500 liquid scintillation spectrom-
eter (Beckman-Coulter Instruments, Palo Alto, CA), the
results were averaged, and the average values were con-
verted to the average fmol of donor substrate transferred/
μg total protein/h using the specific radioactivities of the
donor substrates.
Sialic acid and CMP-sialic acid assays
SAS and CMP-SAS activities were determined by measur-
ing sialic acid and CMP-sialic acid levels in transfected cell
lysates, as described previously [35,36]. Briefly, Sf9 cells
were pre-incubated for 12 h with growth medium con-
taining 10 mM N-acetylmannosamine with or without
1.0 μg/mL doxycycline. The cells were then transfected
with the relevant plasmid DNAs, incubated for another 24
h, rinsed twice with ice-cold TBS buffer, and lysed in cold
TBAS buffer (0.2 M Tris. pH 9.0, 0.2 mM DTT, 20 mM
MgCl2, 1% Triton X-100). The lysates were clarified, total
protein concentrations were determined as described
above, and duplicate assays were performed with samples
containing 1.0 mg of total protein. For the CMP-sialic acid
determinations, the cell lysate was pre-treated with 50 μL
of 1.6 M NaBH4 to reduce the free sialic acid and then with
55 μL of concentrated H3PO4 to destroy the excess NaBH4
and hydrolyze the CMP-sialic acid. The released sialic acid
was oxidized by adding 50 μL of 0.2 M NaIO4 and the
excess NaIO4 was subsequently destroyed by adding 0.4
mL of 4% NaAsO4 in 0.5 M HCl. After vigorous vortexing
to eliminate the brown color, 2 mL of 0.1 M 2-thiobarbi-
turic acid (adjusted to pH 9.0 with NaOH) were added
and the reaction mixtures were incubated in a 100°C
waterbath for 7.5 min to generate the pink chromophore,
which was extracted overnight at room temperature with
4 mL of n-butanol containing 0.6 N HCl. Finally, the
organic phase was collected, absorbance was measured at
532 nm, 549 nm, and 562 nm, and nmol CMP-sialic acid
was calculated using a standard conversion factor (21 ×
OD549 nm - 7.58 × OD532 nm) × 4.0 [35]. The method used
to measure total sialic acid content was the same as
described above except the cell lysates were not pre-
treated with NaBH4. The results were expressed as sialic
acid or CMP-sialic acid content/μg total protein.
Isolation and analysis of transgenic insects
The representative piggyBac vectors used to produce trans-
genic insects were pXLBacII-CMP-SAS/SAS-EYFP.LTR-F cl
25, which encodes CMP-SAS and SAS under the control of
the  ie1-hr5-ie1  dual constitutive transcriptional control
element, and pXLBacII-TetO1.GalT/GnTII-DsRed.A cl 3,
which encodes GalT and GnTII under the control of the
PCMVmin-TetO7-PCMVmin  dual tetracycline-inducible tran-
scriptional element. Drosophila strains were reared under
standard laboratory conditions [37]. D. melanogaster w1118
white eye pre-blastoderm embryos were microinjected as
described previously, except there was no dechorionation
step [38]. pXLBacII-CMP-SAS/SAS-EYFP.LTR-F cl 25 was
injected at a concentration of 0.5 ug/uL together with 0.3
ug/uL of phspBac, which encodes the piggyBac  trans-BMC Biotechnology 2007, 7:5 http://www.biomedcentral.com/1472-6750/7/5
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posase, while pXLBacII-TetO1.GalT/GnTII-DsRed.A cl 3
was injected at a concentration of 0.6 ug/uL together with
0.4 ug/uL of phspBac. To produce a fly line encoding the
transcription factor needed for tetracycline induction,
pBS.rtTAM2-EGFP was co-injected together with phspBac
at equal concentrations of 0.4 ug/uL. One day later, all
microinjected embryos were subjected to a one hour heat
shock at 37°C to induce expression of the piggyBac trans-
posase, and they were subsequently reared at 28°C.
Emerging adults were individually mated with w1118 flies,
and their progeny were screened for fluorescent eye color
as adults using an Olympus SZX12 fluorescent micro-
scope equipped with YFP and RED filter sets. Positive
adults were individually crossed with the w1118 flies and
subsequent generations were produced to establish each
separate, homozygous transgenic fly line. Constitutive
expression of SAS and CMP-SAS was examined by mating
individual adults from the relevant homozygous fly lines,
allowing the females to lay eggs on diet with or without 10
mM N-acetylmannosamine, and rearing the hatched lar-
vae through fourth instar on the same diets. These larvae
were then homogenized in ice-cold TBA buffer and the
homogenates were clarified and used to measure total
protein concentrations and sialic acid and CMP-sialic acid
contents, as described above. To produce transgenic fly
lines capable of inducibly expressing GnTII and GalT,
homozygous adults encoding the rtTAM2 transcription
factor were mated with homozygous adults encoding
GnTII and GalT under the control of the dual tet-inducible
CMV promoter. Progeny were screened for expression of
both EGFP and DsRed and then single males and single
virgin females from each cross were mated. The females
were placed into vials containing diet with or without 50
ug/mL of doxycycline, allowed to lay eggs, and the
hatched larvae were maintained on the same diet for ten
days, homogenized in GnTII or GalT assay buffer, and the
homogenates were clarified and used to measure total
protein concentrations and GnTII and GalT activity levels,
as described above.
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